Abstract:A surface‐enhanced Raman scattering‐based microfluidic assay is developed for profiling small extracellular vesicle glycosylation, to differentiate benign and early‐stage non‐small cell lung cancer patients, which is challenging by commonly used screening tools computed tomography and positron emission tomography. Glycosylation is the most common post‐translational modification of proteins and regulates a myriad of fundamental biological processes under normal, and pathological conditions. Altered protein glycosylation is linked to malignant transformation, showing distinct glycopatterns that are associated with cancer initiation and progression by regulating tumor proliferation, invasion, metastasis, and therapeutic resistance. The glycopatterns of small extracellular vesicles (sEVs) released by cancer cells are promising candidates for cancer monitoring since they exhibit glycopatterns similar to their cell‐of‐origin. However, the clinical application of sEV glycans is challenging due to the limitations of current analytical technologies in tracking the trace amounts of sEVs specifically derived from tumors in circulation. Herein, a sEV GLYcan PHenotype (EV‐GLYPH) assay that utilizes a microfluidic platform integrated with surface‐enhanced Raman scattering for multiplex profiling of sEV glycans in non‐small cell lung cancer is clinically validated. For the first time, the EV‐GLYPH assay effectively identifies distinct sEV glycan signatures between non‐transformed and malignantly transformed lung cells. In a clinical study evaluated on 40 patients, the EV‐GLYPH assay successfully differentiates patients with early‐stage malignant lung nodules from benign lung nodules. These results reveal the potential to profile sEV glycans for noninvasive diagnostics and prognostics, opening up promising avenues for clinical applications and understanding the role of sEV glycosylation in lung cancer.

MALDI-MS-based biomarker analysis of extracellular vesicles from human lung carcinoma cells

[Use of Laser Capture Microdissection and Surface-Enhanced Laser Desorption Ionization Time-of-flight Mass Spectrometry to Screen Differential Proteins in Lung Adenocarcinoma and Lung Squamous Carcinoma].

Comparative Proteomic Analysis of Exosomes and Microvesicles in Human Saliva for Lung Cancer.

Metabolomic investigation of urinary extracellular vesicles for early detection and screening of lung cancer

MALDI Profiling MS Application to Analysis of Non-small Cell Lung Cancer

The Application of MALDI-TOF MS in Mining Different Peptides and Proteins from the Sera of Lung-cancer Patients

Accurate and Convenient Lung Cancer Diagnosis Through Detection of Extracellular Vesicle Membrane Proteins Via Förster Resonance Energy Transfer.

Plasma exosomes contain protein biomarkers valuable for the diagnosis of lung cancer

MALDI-TOF Mass Spectrometry Profiling of Plasma Exosomes Evaluates Osteosarcoma Metastasis

Identification of serum tumormarkers for diagnosing stage Ⅰ lung squamous cell carcinoma by MALDI-TOF mass spectrometry

Mass spectrometry‐based extracellular vesicle micromolecule detection in cancer biomarker discovery: An overview of metabolomics and lipidomics

Application of Laser Capture Microdissection and Surface-enhanced Laser Desorption Ionization Time-of-flight Mass Spectrometry to Screen Biomarkers for Early Diagnosis of Lung Adenocarcinoma

Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers

Plasma-Derived Extracellular Vesicle Proteins As A Source Of Biomarkers For Lung Adenocarcinoma

Study of Distinct Protein Profiles for Early Diagnosis of NSCLC Using LCM and SELDI-TOF-MS

Absolute Quantification and Analysis of Extracellular Vesicle Lncrnas from the Peripheral Blood of Patients with Lung Cancer Based on Multi-Colour Fluorescence Chip-Based Digital PCR.

Membrane proteomic analysis comparing squamous cell lung cancer tissue and tumour-adjacent normal tissue.

Identification of Exosome Protein Panels As Predictive Biomarkers for Non-Small Cell Lung Cancer

Identification of Serum Biomarkers for Lung Cancer Using Magnetic Bead-Based Seldi-Tof-Ms

Glycan Profiling in Small Extracellular Vesicles with a SERS Microfluidic Biosensor Identifies Early Malignant Development in Lung Cancer

Titanium(IV) immobilized affinity chromatography facilitated phosphoproteomics analysis of salivary extracellular vesicles for lung cancer